Developer docs
API playgroundTry for free, no card

Search company profiles

TytoCare

Full company profile

uuid0002pkf

Namestring
TytoCare
Legal namestring
TytoCare Ltd.
Websiteurl
tytocare.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

TytoCare is a telehealth platform that provides FDA-cleared, AI-powered remote physical examination solutions enabling clinical-grade diagnostics outside traditional clinical settings. Founded in 2012 and headquartered in Israel (R&D) and New York (commercial operations), the company offers two core product lines: the Home Smart Clinic, which enables patients to conduct comprehensive remote examinations (heart, lungs, ears, throat, abdomen, skin) from home with AI-powered decision support, and the Pro Smart Clinic, which allows clinicians to conduct or review remote exams from community sites, rural clinics, schools, urgent care, or patient homes. The platform integrates FDA-cleared devices (Tyto Stethoscope, Thermometer, Otoscope, Exam Camera) with the Tyto Insights AI suite, which includes FDA-cleared algorithms for detecting wheeze, crackles, rhonchi, and eardrum bulging, supported by a proprietary dataset of 7M+ clinical examinations.

The company operates a B2B hardware-plus-subscription revenue model, selling devices and recurring software/AI platform access to health systems, health plans, employers, and schools across the U.S., Canada, the U.K., Israel, Japan, and Australia. Pricing is quote-based for health system enterprise contracts (typically multi-year) and per-member-per-month for health plan and employer deployments. The go-to-market combines direct enterprise field sales with channel partnerships, including a strategic collaboration with Teladoc Health announced in late 2025 to integrate the Home Smart Clinic into Teladoc's virtual care programs.

TytoCare has raised $205M+ in venture funding across eight rounds, with a $49M Series E led by Insight Partners in August 2023, and serves 240+ healthcare organizations, 40K+ providers, and 1.6M+ patients globally. In July 2025, the company underwent a strategic restructuring that included a ~20% workforce reduction and the transition of co-founder Dedi Gilad from CEO to chairman, with Adam Pellegrini (former CVS, Walgreens, Fitbit executive) appointed CEO to lead a renewed focus on AI-driven diagnostics and U.S. market expansion.

Short descriptiontext

TytoCare provides FDA-cleared, AI-powered remote physical examination solutions (Home and Pro Smart Clinic) that enable clinical-grade telehealth diagnostics for health systems, health plans, employers, and schools across 240+ healthcare organizations globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote physical examination, telehealth diagnostic devices, AI respiratory diagnostics, virtual primary care, remote patient monitoring
Industry3 codes
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Telehealth Diagnostic Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Hardware and Software Subscription
TypeSubscription Recurring
Description

Health systems purchase TytoCare examination devices and pay recurring software/subscription fees for platform access, AI diagnostics, and provider interface. Revenue is recurring with multi-year contracts typical for health system deployments.

2B2B2C Platform Licensing
TypeSubscription Recurring
Description

Licensing platform to health plans and employers who offer TytoCare as a benefit to their members/employees. Health plans and employers pay per-member-per-month or per-user subscription fees.

Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations, Infrastructure
Pricing details2 tiers
1Enterprise Health System Pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing; includes hardware devices, software platform, AI diagnostics, and support. Multi-year contracts typical.

2Health Plan / Employer Group Pricing
ModelSubscriptionBilling cadenceMonthly
Notes

Per-member-per-month or per-user model. Volume-based pricing tiers based on covered lives.

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Home Smart Clinic
Description

Enabling remote physical exams from the home for accessible, high-quality virtual care

tytocare.com
+2 more records
Core offering1 text field

TytoCare manufactures and sells FDA-cleared handheld remote examination devices (stethoscope, otoscope, thermometer, exam camera) bundled with a cloud-based telehealth platform and AI-powered diagnostic algorithms. Its Home Smart Clinic and Pro Smart Clinic solutions enable clinicians to perform clinical-grade physical exams of the heart, lungs, ears, throat, skin, and abdomen on patients at home or in community settings. The platform is licensed to health systems, health plans, employers, and schools through subscription-based agreements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 98% of visits resolved remotely without requiring in-person follow-up
+2 more records
Product overview1 text field

TytoCare offers a unified telehealth platform with two core product lines (Home Smart Clinic and Pro Smart Clinic) that enable remote physical examinations with clinical-grade diagnostic accuracy. The platform integrates AI-powered diagnostic modules (Tyto Insights) for automated analysis of lung sounds, heart sounds, and ENT images. Tyto Engagement Labs provides behavioral science-based user engagement services to drive adoption. The ecosystem includes FDA-cleared/listed devices (Tyto Stethoscope, Thermometer, Otoscope, Exam Camera) and the Smart Clinic Companion AI guidance system. All components work together to enable health systems, health plans, and employers to deliver comprehensive virtual care from any location.

Product and service4 records
1Home Smart Clinic
CategoryRemote examination platform
Description

FDA-cleared remote physical examination solution that lets patients conduct comprehensive clinical-grade exams at home covering heart, lungs, ears, throat, abdomen, and skin with AI decision support; sold to health plans and employers who offer it as a member/employee benefit.

2Pro Smart Clinic
CategoryRemote examination platform
Description

Clinical-grade remote physical exam device and platform that allows remote clinicians to guide exams live or review captured exam data asynchronously at community sites, rural clinics, schools, urgent care, or patient homes; sold to health systems and providers.

3Tyto Engagement Labs
CategoryEngagement service
Description

User engagement service using behavioral science, real-world insights, and A/B testing to influence consumer decision-making and drive adoption and utilization of the Home Smart Clinic; sold as an add-on service to healthcare organizations.

4Smart Clinic Companion
CategoryAI-guided remote examination
Description

AI-powered virtual care solution that guides patients through clinical-grade remote exams with real-time feedback, quality assessment, and AI interpretation; built on TytoCare's 7M+ multi-modal primary care dataset.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2024-09-01
Description

Strategic collaboration and product integration with Teladoc Health to enhance virtual care capabilities with clinical-grade remote examination technology.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive representative and distributor of TytoCare products in Greece, serving as regional channel partner for the Greek market.

3Cat Lake First Nation
Strategic tierPilotTypeStrategic or Co-development Partner
Description

Partnership for virtual care pilot program bringing TytoCare remote examination technology to remote Indigenous community in Canada.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership for Medical Care at Home program, integrating TytoCare into VNS Health's home-based care services for enhanced remote patient monitoring.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest pure-play telehealth platform offering virtual urgent, primary, and chronic care. Comparable to TytoCare as a virtual care delivery platform now integrating TytoCare's Home Smart Clinic into its 24/7 Care and Primary360 programs, and competes in the same enterprise telehealth deals.

TypeDirect peer
Description

Enterprise telehealth platform serving health systems, health plans, and employers with virtual urgent, specialty, and acute care. Competes with TytoCare in similar enterprise virtual care deals and overlaps in remote patient monitoring strategy.

TypeDirect peer
Description

Maker of FDA-cleared digital stethoscopes with AI auscultation algorithms for heart and lung sound analysis. Directly comparable to TytoCare on AI lung/heart sound detection and on the device-plus-software model used in virtual care workflows.

TypeDirect peer
Description

Handheld, AI-enabled point-of-care ultrasound platform used by clinicians at the bedside. Comparable to TytoCare as a hardware-anchored, AI-driven clinical diagnostic device company selling into similar provider and health system channels.

TypeDirect peer
Description

Multi-sensor remote examination device combining stethoscope, otoscope, thermometer, pulse oximeter, and camera for telehealth. Closest direct competitor to TytoCare's Home/Pro Smart Clinic on form factor, exam capability, and target customers.

TypeDirect peer
Description

Enterprise virtual care platform with bedside telehealth carts, mobile devices, and AI tools for inpatient and outpatient settings. Comparable to TytoCare in targeting health systems with clinical-grade virtual care and integrated hardware-software offerings.

TypeDirect peer
Description

Integrated virtual care and navigation platform combining 24/7 telehealth with in-person and behavioral health. Comparable to TytoCare on the B2B2C virtual primary care motion targeting health plans and employers.

8Biofourmis
TypeEmerging player
Description

AI-driven remote monitoring and virtual care platform focused on chronic condition management at home. Comparable to TytoCare on AI-enabled remote patient monitoring and health system / pharma partnerships, with overlapping heart and lung monitoring capabilities.

TypeBroad incumbent
Description

Optum-owned remote patient monitoring platform providing connected kits and care pathways for chronic and post-acute care. Comparable to TytoCare in RPM and home-based monitoring, with broader portfolio reach through UnitedHealth/Optum.

TypeDirect peer
Description

Provider of telehealth carts, examination cameras, stethoscopes, and otoscopes for clinical-grade remote examinations. Comparable to TytoCare on hardware-anchored clinical remote examination and shared enterprise health system sales motion.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors22 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TytoCare

Telehealth Diagnostic Devicestytocare.com

TytoCare provides FDA-cleared, AI-powered remote physical examination solutions (Home and Pro Smart Clinic) that enable clinical-grade telehealth diagnostics for health systems, health plans, employers, and schools across 240+ healthcare organizations globally.

What TytoCare does

TytoCare is a telehealth platform that provides FDA-cleared, AI-powered remote physical examination solutions enabling clinical-grade diagnostics outside traditional clinical settings. Founded in 2012 and headquartered in Israel (R&D) and New York (commercial operations), the company offers two core product lines: the Home Smart Clinic, which enables patients to conduct comprehensive remote examinations (heart, lungs, ears, throat, abdomen, skin) from home with AI-powered decision support, and the Pro Smart Clinic, which allows clinicians to conduct or review remote exams from community sites, rural clinics, schools, urgent care, or patient homes. The platform integrates FDA-cleared devices (Tyto Stethoscope, Thermometer, Otoscope, Exam Camera) with the Tyto Insights AI suite, which includes FDA-cleared algorithms for detecting wheeze, crackles, rhonchi, and eardrum bulging, supported by a proprietary dataset of 7M+ clinical examinations.

The company operates a B2B hardware-plus-subscription revenue model, selling devices and recurring software/AI platform access to health systems, health plans, employers, and schools across the U.S., Canada, the U.K., Israel, Japan, and Australia. Pricing is quote-based for health system enterprise contracts (typically multi-year) and per-member-per-month for health plan and employer deployments. The go-to-market combines direct enterprise field sales with channel partnerships, including a strategic collaboration with Teladoc Health announced in late 2025 to integrate the Home Smart Clinic into Teladoc's virtual care programs.

TytoCare has raised $205M+ in venture funding across eight rounds, with a $49M Series E led by Insight Partners in August 2023, and serves 240+ healthcare organizations, 40K+ providers, and 1.6M+ patients globally. In July 2025, the company underwent a strategic restructuring that included a ~20% workforce reduction and the transition of co-founder Dedi Gilad from CEO to chairman, with Adam Pellegrini (former CVS, Walgreens, Fitbit executive) appointed CEO to lead a renewed focus on AI-driven diagnostics and U.S. market expansion.

TytoCare firmographics

Firmographics
Name
TytoCare
Legal name
TytoCare Ltd.
Website
https://tytocare.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
101–250 employees
Short description
TytoCare provides FDA-cleared, AI-powered remote physical examination solutions (Home and Pro Smart Clinic) that enable clinical-grade telehealth diagnostics for health systems, health plans, employers, and schools across 240+ healthcare organizations globally.
Ownership category
akta.pro rank

TytoCare industry classification

Industry
Product category
Telehealth Diagnostic Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Remote physical examination
  • Telehealth diagnostic devices
  • AI respiratory diagnostics
  • Virtual primary care
  • Remote patient monitoring

Where TytoCare is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

TytoCare business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations, Infrastructure

Revenue model

  1. Hardware and Software Subscription: Health systems purchase TytoCare examination devices and pay recurring software/subscription fees for platform access, AI diagnostics, and provider interface. Revenue is recurring with multi-year contracts typical for health system deployments.
  2. B2B2C Platform Licensing: Licensing platform to health plans and employers who offer TytoCare as a benefit to their members/employees. Health plans and employers pay per-member-per-month or per-user subscription fees.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise Health System Pricing
SubscriptionMonthlyHealth Plan / Employer Group Pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

TytoCare product offering

Product offering

Core offering

TytoCare manufactures and sells FDA-cleared handheld remote examination devices (stethoscope, otoscope, thermometer, exam camera) bundled with a cloud-based telehealth platform and AI-powered diagnostic algorithms. Its Home Smart Clinic and Pro Smart Clinic solutions enable clinicians to perform clinical-grade physical exams of the heart, lungs, ears, throat, skin, and abdomen on patients at home or in community settings. The platform is licensed to health systems, health plans, employers, and schools through subscription-based agreements.

Product overview

TytoCare offers a unified telehealth platform with two core product lines (Home Smart Clinic and Pro Smart Clinic) that enable remote physical examinations with clinical-grade diagnostic accuracy. The platform integrates AI-powered diagnostic modules (Tyto Insights) for automated analysis of lung sounds, heart sounds, and ENT images. Tyto Engagement Labs provides behavioral science-based user engagement services to drive adoption. The ecosystem includes FDA-cleared/listed devices (Tyto Stethoscope, Thermometer, Otoscope, Exam Camera) and the Smart Clinic Companion AI guidance system. All components work together to enable health systems, health plans, and employers to deliver comprehensive virtual care from any location.

Differentiator

Problem solved

Functional benefit

Brands

  • Home Smart Clinic: Enabling remote physical exams from the home for accessible, high-quality virtual care
  • Pro Smart Clinic
  • Tyto Engagement Labs

Products and services

  • Home Smart Clinic FDA-cleared remote physical examination solution that lets patients conduct comprehensive clinical-grade exams at home covering heart, lungs, ears, throat, abdomen, and skin with AI decision support; sold to health plans and employers who offer it as a member/employee benefit.
  • Pro Smart Clinic Clinical-grade remote physical exam device and platform that allows remote clinicians to guide exams live or review captured exam data asynchronously at community sites, rural clinics, schools, urgent care, or patient homes; sold to health systems and providers.
  • Tyto Engagement Labs User engagement service using behavioral science, real-world insights, and A/B testing to influence consumer decision-making and drive adoption and utilization of the Home Smart Clinic; sold as an add-on service to healthcare organizations.
  • Smart Clinic Companion AI-powered virtual care solution that guides patients through clinical-grade remote exams with real-time feedback, quality assessment, and AI interpretation; built on TytoCare's 7M+ multi-modal primary care dataset.

Quantifiable outcome

  • 98% of visits resolved remotely without requiring in-person follow-up
  • +2 more outcomes

Companies that use TytoCare

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

TytoCare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature6 records

TytoCare partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered strategic, regional and pilot.

  • Teladoc HealthstrategicTechnology or Integration · 1 September 2024Strategic collaboration and product integration with Teladoc Health to enhance virtual care capabilities with clinical-grade remote examination technology.
  • EmergencyHelpregionalChannel Partner/ Reseller/ DistributorExclusive representative and distributor of TytoCare products in Greece, serving as regional channel partner for the Greek market.
  • Cat Lake First NationpilotStrategic or Co-development PartnerPartnership for virtual care pilot program bringing TytoCare remote examination technology to remote Indigenous community in Canada.
  • VNS HealthstrategicStrategic or Co-development PartnerPartnership for Medical Care at Home program, integrating TytoCare into VNS Health's home-based care services for enhanced remote patient monitoring.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

TytoCare competitors and assessment

Company assessment

Direct peers

  • Teladoc Health: Largest pure-play telehealth platform offering virtual urgent, primary, and chronic care. Comparable to TytoCare as a virtual care delivery platform now integrating TytoCare's Home Smart Clinic into its 24/7 Care and Primary360 programs, and competes in the same enterprise telehealth deals.
  • Amwell: Enterprise telehealth platform serving health systems, health plans, and employers with virtual urgent, specialty, and acute care. Competes with TytoCare in similar enterprise virtual care deals and overlaps in remote patient monitoring strategy.
  • Eko Health: Maker of FDA-cleared digital stethoscopes with AI auscultation algorithms for heart and lung sound analysis. Directly comparable to TytoCare on AI lung/heart sound detection and on the device-plus-software model used in virtual care workflows.
  • Butterfly Network: Handheld, AI-enabled point-of-care ultrasound platform used by clinicians at the bedside. Comparable to TytoCare as a hardware-anchored, AI-driven clinical diagnostic device company selling into similar provider and health system channels.
  • MedWand Solutions: Multi-sensor remote examination device combining stethoscope, otoscope, thermometer, pulse oximeter, and camera for telehealth. Closest direct competitor to TytoCare's Home/Pro Smart Clinic on form factor, exam capability, and target customers.
  • Caregility: Enterprise virtual care platform with bedside telehealth carts, mobile devices, and AI tools for inpatient and outpatient settings. Comparable to TytoCare in targeting health systems with clinical-grade virtual care and integrated hardware-software offerings.
  • Included Health (Doctor On Demand): Integrated virtual care and navigation platform combining 24/7 telehealth with in-person and behavioral health. Comparable to TytoCare on the B2B2C virtual primary care motion targeting health plans and employers.
  • AMD Global Telemedicine: Provider of telehealth carts, examination cameras, stethoscopes, and otoscopes for clinical-grade remote examinations. Comparable to TytoCare on hardware-anchored clinical remote examination and shared enterprise health system sales motion.

Emerging players

  • Biofourmis: AI-driven remote monitoring and virtual care platform focused on chronic condition management at home. Comparable to TytoCare on AI-enabled remote patient monitoring and health system / pharma partnerships, with overlapping heart and lung monitoring capabilities.

Broad incumbents

  • Vivify Health (Optum): Optum-owned remote patient monitoring platform providing connected kits and care pathways for chronic and post-acute care. Comparable to TytoCare in RPM and home-based monitoring, with broader portfolio reach through UnitedHealth/Optum.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

TytoCare social profiles

Digital presence

TytoCare compliance and trust

Trust signal

Compliance6 records

TytoCare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TytoCare leadership team

Management profile

Number of profiles

Profiles13 records

TytoCare funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors22 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TytoCare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TytoCare

What does TytoCare do?

TytoCare manufactures and sells FDA-cleared handheld remote examination devices (stethoscope, otoscope, thermometer, exam camera) bundled with a cloud-based telehealth platform and AI-powered diagnostic algorithms. Its Home Smart Clinic and Pro Smart Clinic solutions enable clinicians to perform clinical-grade physical exams of the heart, lungs, ears, throat, skin, and abdomen on patients at home or in community settings. The platform is licensed to health systems, health plans, employers, and schools through subscription-based agreements.

Is TytoCare a public or private company?

TytoCare is a private company. It is classified as venture growth investor backed and is currently operating.

When was TytoCare founded?

TytoCare was founded in 2012. It employs 101 to 250 people.

Where is TytoCare based?

TytoCare is headquartered in New York, United States, in the North America region.

How does TytoCare make money?

Two revenue lines are on record. Hardware and Software Subscription is the primary driver. The others are B2B2C Platform Licensing.

Who are TytoCare's main competitors?

Direct peers on record are Teladoc Health, Amwell, Eko Health, Butterfly Network, MedWand Solutions, Caregility, Included Health (Doctor On Demand) and AMD Global Telemedicine. Biofourmis is listed as an emerging player. Vivify Health (Optum) is listed as a broad incumbent.

Does TytoCare have an API?

No public API is recorded for TytoCare.

What industry is TytoCare in?

TytoCare's product category is Telehealth Diagnostic Devices. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogTytoCare Launches AI Care Enablement Platform and Unveils Tyto Health Hub™ to Manage High-Risk, High-Cost Patients at HomeTytoCare launched its AI Care Enablement Platform and Tyto Health Hub to manage high-risk patients at home, built on virtual care used by 240+ organizations and 1.6M+ patients. The platform extends remote exams to cardiopulmonary and oncology conditions, with first patients enrolling by year-end. It aligns with CMS's new Medicare policy requiring remote monitoring by clinical staff.//telecareaware.com/The week that was in M&A, financings: Included Health buys Firefly, Candid’s $120M raise, DarioHealth’s $23M RDO, TytoCare’s $25M growth round + new execs, Aurenar’s $5.7M seed for ICU neuromodulationIncluded Health acquired Firefly Health, adding a virtual-first health plan; Candid raised $120M Series D, DarioHealth raised $23.5M RDO, and TytoCare raised $25M growth round. Aurenar raised $5.7M seed for ICU neuromodulation. Deals are expected to close in Q3 2026.AlleyWatchThe AlleyWatch Startup Daily Funding Report: 7/16/2026Three NYC-based startups announced funding rounds on July 16, 2026: Wonder raised $650M in Series D funding for its food technology platform, Fora secured $60M in Series D funding for its travel advisor platform, and TytoCare raised $25M in venture funding for its AI-powered remote physical examination technology.MobiHealthNewsTytoCare scores $25M, appoints new CEO and COOTytoCare, a New York-based telehealth company offering AI-enabled remote physical examination technology, closed an oversubscribed $25 million-plus growth round led by Insight Partners with participation from OliveTree, HOOP, Qumra Capital, Qualcomm Ventures, OrbiMed and others. The company appointed Adam Pellegrini as new CEO, replacing cofounder Dedi Gilad who served as CEO for 13 years and will remain as chairman, while Greg Orr joined as COO from his previous role at Walgreens. The funding will be used to expand AI clinical algorithms, deepen payer and health system partnerships, and accelerate go-to-market efforts in cardiometabolic and cancer care areas.HIT ConsultantTytoCare Secures $25M and Appoints Adam Pellegrini as CEOTytoCare, a telehealth company, has secured $25 million in an oversubscribed growth financing round led by Insight Partners, with participation from Qualcomm Ventures, OrbiMed, HOOP, OliveTree, and Qumra Capital. The company appointed Adam Pellegrini, a digital health veteran with executive experience at CVS Health, Fitbit, and Walgreens, as CEO, alongside Greg Orr—former Walgreens digital health leader and COO of Jasper Health—as COO. The funding will support TytoCare's strategic pivot from low-acuity episodic care to high-acuity chronic disease management, targeting conditions including congestive heart failure, COPD, post-surgical recovery, and oncology treatment monitoring through its FDA-cleared AI-powered remote examination platform.BioWorldFinancings for July 16, 2026BioWorld reported financings for July 16, 2026, covering biopharma and med-tech companies including Advancell, Attovia, Braveheart, Cardiff, Crescent, Kestra, Neko Health, Q32, Senhwa, Think Surgical, and Tytocare. The full story requires subscription or sign-in.Pulse 2.0TytoCare Names Adam Pellegrini As CEO And Closes $25+ Million Growth Round To Scale AI-First Clinical Enablement PlatformTytoCare appointed Adam Pellegrini as Chief Executive Officer and closed a $25 million-plus oversubscribed growth round led by Insight Partners, with participation from multiple investors including HOOP, OliveTree, OrbiMed, Qumra Capital, and Qualcomm Ventures. The company is repositioning itself as an AI-first clinical enablement platform, expanding its FDA-cleared remote examination technology and AI diagnostic algorithms into chronic disease management, cardiopulmonary monitoring, and oncology support. Proceeds will fund AI algorithm development, payer and health system partnerships, and go-to-market efforts targeting cardiometabolic patients, cancer treatment populations, and post-acute care transitions.InfotechLeadTytoCare Raises Over $25 mn Led by Insight Partners, Appoints Adam Pellegrini as CEO to Expand AI-Powered Remote CareTytoCare, an AI-first clinical enablement company specializing in remote physical examination technology, has secured an oversubscribed growth funding round of more than $25 million led by Insight Partners, with participation from multiple investors including Qumra Capital, Qualcomm Ventures, and others. The company appointed Adam Pellegrini as CEO and Greg Orr as COO to accelerate expansion into AI-powered remote care for chronic and complex diseases including heart failure, COPD, oncology, and cardiometabolic conditions. TytoCare plans to use the capital to expand its FDA-cleared AI-powered Software as a Medical Device algorithms and strengthen partnerships with health systems and payers worldwide.citybizTytoCare Appoints Adam Pellegrini CEO, Raises Over $25 Million to Expand AI-Driven Virtual CareTytoCare appointed Adam Pellegrini CEO and closed an oversubscribed growth financing of over $25 million led by Insight Partners. The capital will expand its AI-powered remote care platform for chronic and complex conditions, with proceeds supporting algorithm development and commercialization. The company is targeting broader adoption in chronic disease management and care transitions.TytoCareTytoCare Names Adam Pellegrini as CEO and Closes $25M+ Growth Round to Scale AI-First Clinical Enablement PlatformTytoCare appointed Adam Pellegrini as CEO and closed a $25 million-plus growth round led by Insight Partners. The company is repositioning as an AI-first clinical enablement platform, embedding FDA-cleared remote examination devices and AI algorithms into virtual primary care for cardiopulmonary and oncology patients. Proceeds will fund expansion of its AI pipeline and payer partnerships.